Literature DB >> 19703539

Towards a better understanding of the psychopharmacology of nutmeg: Activities in the mouse tetrad assay.

Abir T El-Alfy1, Lisa Wilson, Mahmoud A ElSohly, Ehab A Abourashed.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Nutmeg, the seeds of Myritica fragrans (family Myristicaceae), is a well known kitchen spice with a long-standing reputation as a psychoactive herb. Nutmeg at high doses is considered a cheap substitute to several drugs of abuse. Earlier reports have attributed amphetamine-like activities to nutmeg. AIM OF THE STUDY: To characterize the neuropharmacological effects of different nutmeg extracts, administered orally and intraperitoneally, in comparison to Delta(9)-terahydrocannabinol, amphetamine, and morphine.
MATERIALS AND METHODS: Methanolic (ME), dichloromethane (DE), and hexane (HE) extracts were obtained from a chromatographically fingerprinted batch of nutmeg. Biological evaluation was conducted in sets of 6-8 mice in the tetrad assay at doses ranging from 100 to 500 and 500 to 1000 mg/kg for i.p. and oral administration, respectively.
RESULTS: While oral administration of all the nutmeg extracts at 500 mg/kg caused a significant increase in locomotor activity, the i.p. administration of DE showed significant reduction in rectal temperature along with a significant increase in tail flick latency at 300 mg/kg. A significant decrease in core body temperature was observed with HE at 100 mg/kg, while higher doses caused significant increases in hot plate latency.
CONCLUSION: Different behavioral effects were observed that varied by the type of extract as well as by the route of administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703539      PMCID: PMC2783227          DOI: 10.1016/j.jep.2009.08.026

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  39 in total

1.  Nutmeg and psychosis.

Authors:  Brendan D Kelly; Blanaid E Gavin; Mary Clarke; Abbie Lane; Conall Larkin
Journal:  Schizophr Res       Date:  2003-03-01       Impact factor: 4.939

2.  Nutmeg intoxication in Texas, 1998-2004.

Authors:  Mathias B Forrester
Journal:  Hum Exp Toxicol       Date:  2005-11       Impact factor: 2.903

3.  Anxiogenic activity of Myristica fragrans seeds.

Authors:  G S Sonavane; V P Sarveiya; V S Kasture; S B Kasture
Journal:  Pharmacol Biochem Behav       Date:  2002 Jan-Feb       Impact factor: 3.533

4.  Letter: Nutmeg toxicology.

Authors:  I Shafran
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

5.  Nutmeg oil: identification and quantitation of its most active constituents as inhibitors of platelet aggregation.

Authors:  J Janssens; G M Laekeman; L A Pieters; J Totte; A G Herman; A J Vlietinck
Journal:  J Ethnopharmacol       Date:  1990-05       Impact factor: 4.360

6.  Abuse of nutmeg (Myristica fragrans Houtt.): studies on the metabolism and the toxicologic detection of its ingredients elemicin, myristicin, and safrole in rat and human urine using gas chromatography/mass spectrometry.

Authors:  Jochen Beyer; Dorothea Ehlers; Hans H Maurer
Journal:  Ther Drug Monit       Date:  2006-08       Impact factor: 3.681

7.  Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.

Authors:  B R Martin; D R Compton; W R Prescott; R L Barrett; R K Razdan
Journal:  Drug Alcohol Depend       Date:  1995-03       Impact factor: 4.492

8.  Pain measurement: an overview.

Authors:  C R Chapman; K L Casey; R Dubner; K M Foley; R H Gracely; A E Reading
Journal:  Pain       Date:  1985-05       Impact factor: 6.961

9.  Antinociceptive effect of topiramate in models of acute pain and diabetic neuropathy in rodents.

Authors:  L S Lopes; S S Pereira; L L Silva; K A Figueiredo; B A Moura; F R C Almeida; F C F Sousa
Journal:  Life Sci       Date:  2008-11-17       Impact factor: 5.037

10.  Cannabinoid pharmacological properties common to other centrally acting drugs.

Authors:  Jenny L Wiley; Billy R Martin
Journal:  Eur J Pharmacol       Date:  2003-06-27       Impact factor: 4.432

View more
  6 in total

1.  Chemical diversity and pharmacological significance of the secondary metabolites of nutmeg (Myristica fragrans Houtt.).

Authors:  Ehab A Abourashed; Abir T El-Alfy
Journal:  Phytochem Rev       Date:  2016-05-10       Impact factor: 5.374

2.  HPLC-Guided Isolation, Purification and Characterization of Phenylpropanoid and Phenolic Constituents of Nutmeg Kernel (Myristica fragrans).

Authors:  Sharon Chiu; Thomas Wang; Martin Belski; Ehab A Abourashed
Journal:  Nat Prod Commun       Date:  2016-04       Impact factor: 0.986

3.  Myristica fragrans seed extract reverses scopolamine-induced cortical injury via stimulation of HO-1 expression in male rats.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Rewaida Abdel-Gaber; Rafat Zrieq; Taghreed A Hafez; Murad A Mubaraki; Ahmed E Abdel Moneim
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-28       Impact factor: 4.223

4.  Phenolic compounds from nutmeg (Myristica fragrans Houtt.) inhibit the endocannabinoid-modulating enzyme fatty acid amide hydrolase.

Authors:  Abir T El-Alfy; Ehab A Abourashed; Christina Patel; Nunmoula Mazhari; HeaRe An; Andrew Jeon
Journal:  J Pharm Pharmacol       Date:  2019-10-08       Impact factor: 3.765

5.  Acaricidal activity of five essential oils of Ocimum species on Rhipicephalus (Boophilus) microplus larvae.

Authors:  T Hüe; L Cauquil; J B Hzounda Fokou; P M Jazet Dongmo; I Bakarnga-Via; C Menut
Journal:  Parasitol Res       Date:  2014-10-11       Impact factor: 2.289

Review 6.  Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development.

Authors:  Charu Sharma; Bassem Sadek; Sameer N Goyal; Satyesh Sinha; Mohammad Amjad Kamal; Shreesh Ojha
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-17       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.